Ranking of Increasing Margin Buying Positions in Japan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	Margin Ratio	Buy Positions(Shares)	Weekly Change	Market Cap	Liquidity
BrightPath Biotherapeutics 4594 TSE Growth	63	-2 -3.1%	3,037,500	10.94	18,110,200	+6,970,300	7.12B	Slightly High
TORICO 7138 TSE Growth	341	-23 -6.3%	1,438,000	1,026.27	2,668,300	+674,200	5.1B	High
NAKAMURA CHOUKOU 6166 TSE Growth	604	-78 -11%	2,400,800	24.94	1,082,500	+650,400	6.66B	Slightly High
Solasia Pharma 4597 TSE Growth	28	-1 -3.5%	26,657,300	12.53	21,900,000	+591,100	7.38B	Mid
SymBio Pharma 4582 TSE Growth	86	-2 -2.3%	1,135,100	0.00	4,870,400	+426,000	5.12B	Mid
JELLY BEANS 3070 TSE Growth	109	+3 +2.83%	25,984,200	870.53	8,705,300	+315,400	8.62B	Slightly High
Modalis Therapeutics 4883 TSE Growth	59	-1 -1.7%	263,000	0.00	9,670,900	+218,800	5.11B	Slightly High
Globalway 3936 TSE Growth	140	+1 +0.72%	163,300	0.00	3,078,900	+103,700	5.12B	Slightly High
MetaReal 6182 TSE Growth	507	-17 -3.2%	92,400	2.83	766,900	+82,500	5.52B	Mid
Carna Biosciences 4572 TSE Growth	414	-19 -4.4%	205,300	0.00	1,939,500	+72,100	7.93B	Slightly High
VisasQ 4490 TSE Growth	589	-36 -5.8%	72,600	0.00	415,900	+70,800	5.46B	Mid
Chordia Therapeutics 190A TSE Growth	128	+6 +4.92%	1,072,500	0.00	4,467,300	+70,500	9.11B	Slightly High
Chiome Bioscience 4583 TSE Growth	112	-1 -0.9%	287,800	0.00	5,030,300	+61,300	7.67B	Slightly High
Cyfuse Biomedical 4892 TSE Growth	655	+15 +2.34%	90,000	0.00	1,060,800	+52,800	6.53B	Slightly High
MEDINET 2370 TSE Growth	31	0 ー%	3,655,100	0.00	11,483,300	+39,100	8.21B	Mid
TMS 4891 TSE Growth	151	+1 +0.67%	250,000	0.00	3,475,800	+32,100	6.87B	Slightly High
ASNOVA 9223 TSE Growth	555	+1 +0.18%	2,800	0.00	379,500	+30,000	6.9B	Slightly Low
Tsubota Lab 4890 TSE Growth	316	+1 +0.32%	19,200	0.00	607,100	+27,300	8.15B	Mid
Soiken Holdings 2385 TSE Growth	244	0 ー%	56,600	0.00	1,005,300	+27,200	6.38B	Mid
Nihon Jyoho Create 4054 TSE Growth	626	-7 -1.1%	63,000	16.81	210,100	+20,900	9B	Mid

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels